热门资讯> 正文
智能生物解决方案报告初步未经审计的第三财年业绩
2024-04-19 02:58
- Intelligent Bio Solutions press release (NASDAQ:INBS): Q3 The Company expects approximate unaudited revenue of $0.82 million for the three months ended March 31, 2024,
- INBS expects a year-over-year increase of 17% in cartridge sales and 20% in reader sales for the three months ended March 31, 2024,
-
More on Intelligent Bio Solutions
- Intelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M
- Seeking Alpha’s Quant Rating on Intelligent Bio Solutions
- Historical earnings data for Intelligent Bio Solutions
- Financial information for Intelligent Bio Solutions
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。